Schedule 13D ownership disclosure
PROTEON THERAPEUTICS INC
Security class unavailable · CUSIP: 74371L109
Event date: 2017-06-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-17-000632
- Form type
- SC 13D
- Filer
- Abingworth LLP
- CIK
- CIK 1397144
- Filed
- Jun 27, 2017
- Reporting period
- Jun 22, 2017
- Description
- Schedule 13D beneficial ownership